Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,851 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life.
Keetharuth AD, Gould RL, McDermott CJ, Thompson BJ, Rawlinson C, Bradburn M, Bursnall M, Kumar P, Turton EJ, Tappenden P, White D, Howard RJ, Serfaty MA, McCracken LM, Graham CD, Al-Chalabi A, Goldstein LH, Lawrence V, Cooper C, Young T; COMMEND Collaboration Group. Keetharuth AD, et al. Among authors: young t. Eur J Neurol. 2024 Apr 25:e16317. doi: 10.1111/ene.16317. Online ahead of print. Eur J Neurol. 2024. PMID: 38660985
Needs and preferences for psychological interventions of people with motor neuron disease.
Weeks KR, Gould RL, Mcdermott C, Lynch J, Goldstein LH, Graham CD, McCracken L, Serfaty M, Howard R, Al-Chalabi A, White D, Bradburn M, Young T, Cooper C, Shaw DPJ, Lawrence V. Weeks KR, et al. Among authors: young t. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):521-531. doi: 10.1080/21678421.2019.1621344. Epub 2019 Jul 12. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31298054 Free article.
A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.
Gould RL, Thompson BJ, Rawlinson C, Kumar P, White D, Serfaty MA, Graham CD, McCracken LM, Bursnall M, Bradburn M, Young T, Howard RJ, Al-Chalabi A, Goldstein LH, Lawrence V, Cooper C, Shaw PJ, McDermott CJ. Gould RL, et al. Among authors: young t. BMC Neurol. 2022 Nov 15;22(1):431. doi: 10.1186/s12883-022-02950-5. BMC Neurol. 2022. PMID: 36380299 Free PMC article.
An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT.
Mountain G, Wright J, Cooper CL, Lee E, Sprange K, Beresford-Dent J, Young T, Walters S, Berry K, Dening T, Loban A, Turton E, Thomas BD, Young EL, Thompson BJ, Crawford B, Craig C, Bowie P, Moniz-Cook E, Foster A. Mountain G, et al. Among authors: young el, young t. Health Technol Assess. 2022 May;26(24):1-152. doi: 10.3310/KHHA0861. Health Technol Assess. 2022. PMID: 35536231 Free PMC article. Clinical Trial.
The Journeying through Dementia psychosocial intervention versus usual care study: a single-blind, parallel group, phase 3 trial.
Mountain GA, Cooper CL, Wright J, Walters SJ, Lee E, Craig C, Berry K, Sprange K, Young T, Moniz-Cook E, Dening T, Loban A, Turton E, Beresford-Dent J, Thomas BD, Thompson BJ, Young EL. Mountain GA, et al. Among authors: young el, young t. Lancet Healthy Longev. 2022 Apr;3(4):e276-e285. doi: 10.1016/S2666-7568(22)00059-9. Epub 2022 Apr 4. Lancet Healthy Longev. 2022. PMID: 36098301 Free article. Clinical Trial.
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Julious SA, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude E, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Bouhassira D, Bennett DL, Selvarajah D. Tesfaye S, et al. Among authors: young t. Health Technol Assess. 2022 Oct;26(39):1-100. doi: 10.3310/RXUO6757. Health Technol Assess. 2022. PMID: 36259684 Free PMC article. Clinical Trial.
Study protocol for a randomised controlled trial assessing the clinical and cost-effectiveness of the Journeying through Dementia (JtD) intervention compared to usual care.
Wright J, Foster A, Cooper C, Sprange K, Walters S, Berry K, Moniz-Cook E, Loban A, Young TA, Craig C, Dening T, Lee E, Beresford-Dent J, Thompson BJ, Young E, Thomas BD, Mountain G. Wright J, et al. Among authors: young ta, young e. BMJ Open. 2019 Sep 13;9(9):e029207. doi: 10.1136/bmjopen-2019-029207. BMJ Open. 2019. PMID: 31519673 Free PMC article.
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D, Petrie J, White D, Julious S, Bortolami O, Cooper C, Bradburn M, Loban A, Bowler H, Swaby L, Sutherland K, Tesfaye S; OPTION-DM group. Selvarajah D, et al. Trials. 2018 Oct 22;19(1):578. doi: 10.1186/s13063-018-2959-y. Trials. 2018. PMID: 30348206 Free PMC article.
Use of a modified World Café process to discuss and set priorities for a Community of Practice supporting implementation of ReQoL a new mental health and quality of life Patient Reported Outcome Measure (PROM).
Taylor Buck E, Smith CM, Lane A, Keetharuth AD, Young T, Cooke J. Taylor Buck E, et al. Among authors: young t. J Patient Rep Outcomes. 2020 May 19;4(1):38. doi: 10.1186/s41687-020-00202-z. J Patient Rep Outcomes. 2020. PMID: 32430640 Free PMC article. No abstract available.
2,851 results